Abstract
The efficacy of BW942C, a novel enkephalinlike pentapeptide antidiarrheal agent, was compared with the efficacy of trimethoprim-sulfamethoxazole (TMP-SMX) and the combination of the two agents in a placebo-controlled trial of the 72-h treatment of acute diarrhea. Subjects with diarrhea but without bloody stools or fever greater than 102 degrees F (38.9 degrees C) were enrolled. Administered to 134 U.S. adults with diarrhea that developed shortly after their arrival in Guadalajara, Mexico, BW942C was more efficacious than TMP-SMX in relieving diarrhea and cramps in the first 12 h of therapy, especially among subjects with diarrhea caused by enterotoxigenic E. coli. In the BW942C treatment group, 25% of subjects eventually took additional therapy because their diarrhea did not respond to BW942C alone. Neurological side effects such as dizziness and light-headedness occurred more frequently among BW942C-treated subjects. Therapy for 3 days with TMP-SMX provided lasting relief comparable with previously reported 5-day therapy. Use of the combination of both agents provided the benefits of prompt relief afforded by BW942C and lasting relief afforded by TMP-SMX. BW942C might prove to be an agent suitable for the treatment of acute diarrhea, with TMP-SMX reserved for treatment of those who do not respond adequately. The empiric use of the combination of BW942C and TMP-SMX appears appropriate for the treatment of severe nondysenteric disease.
Full text
PDF![1040](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24a4/180497/9575eaedddc8/aac00172-0108.png)
![1041](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24a4/180497/4865e4b98d62/aac00172-0109.png)
![1042](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24a4/180497/ee007b5bd33c/aac00172-0110.png)
![1043](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24a4/180497/51f15613b224/aac00172-0111.png)
![1044](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24a4/180497/429dd625f2e9/aac00172-0112.png)
![1045](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24a4/180497/beae6e989047/aac00172-0113.png)
![1046](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24a4/180497/553cec55cf89/aac00172-0114.png)
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- DuPont H. L., Evans D. G., Rios N., Cabada F. J., Evans D. J., Jr, DuPont M. W. Prevention of travelers' diarrhea with trimethoprim-sulfamethoxazole. Rev Infect Dis. 1982 Mar-Apr;4(2):533–539. doi: 10.1093/clinids/4.2.533. [DOI] [PubMed] [Google Scholar]
- DuPont H. L., Galindo E., Evans D. G., Cabada F. J., Sullivan P., Evans D. J., Jr Prevention of travelers' diarrhea with trimethoprim-sulfamethoxazole and trimethoprim alone. Gastroenterology. 1983 Jan;84(1):75–80. [PubMed] [Google Scholar]
- DuPont H. L., Hornick R. B. Adverse effect of lomotil therapy in shigellosis. JAMA. 1973 Dec 24;226(13):1525–1528. [PubMed] [Google Scholar]
- DuPont H. L., Reves R. R., Galindo E., Sullivan P. S., Wood L. V., Mendiola J. G. Treatment of travelers' diarrhea with trimethoprim/sulfamethoxazole and with trimethoprim alone. N Engl J Med. 1982 Sep 30;307(14):841–844. doi: 10.1056/NEJM198209303071401. [DOI] [PubMed] [Google Scholar]
- Dupont H. L., Haynes G. A., Pickering L. K., Tjoa W., Sullivan P., Olarte J. Diarrhea of travelers to Mexico. Relative susceptibility of United States and Latin American students attending a Mexican University. Am J Epidemiol. 1977 Jan;105(1):37–41. doi: 10.1093/oxfordjournals.aje.a112353. [DOI] [PubMed] [Google Scholar]
- Ericsson C. D., DuPont H. L., Galindo E., Mathewson J. J., Morgan D. R., Wood L. V., Mendiola J. Efficacy of bicozamycin in preventing traveler's diarrhea. Gastroenterology. 1985 Feb;88(2):473–477. doi: 10.1016/0016-5085(85)90509-8. [DOI] [PubMed] [Google Scholar]
- Ericsson C. D., DuPont H. L., Sullivan P., Galindo E., Evans D. G., Evans D. J., Jr Bicozamycin, a poorly absorbable antibiotic, effectively treats travelers' diarrhea. Ann Intern Med. 1983 Jan;98(1):20–25. doi: 10.7326/0003-4819-98-1-20. [DOI] [PubMed] [Google Scholar]
- Morgan D. R., Sellin J., Gutierrez L., DuPont H. L., Wood L. V. Evaluation of BW942C, a novel antidiarrheal agent, against enterotoxins of Escherichia coli and Vibrio cholerae. Infect Immun. 1985 Jun;48(3):754–758. doi: 10.1128/iai.48.3.754-758.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pickering L. K., DuPont H. L., Olarte J. Single-dose tetracycline therapy for shigellosis in adults. JAMA. 1978 Feb 27;239(9):853–854. [PubMed] [Google Scholar]
- Thorén A., Wolde-Mariam T., Stintzing G., Wadström T., Habte D. Antibiotics in the treatment of gastroenteritis caused by enteropathogenic Escherichia coli. J Infect Dis. 1980 Jan;141(1):27–31. doi: 10.1093/infdis/141.1.27. [DOI] [PubMed] [Google Scholar]